C07K 7/23
Luteinising hormone-releasing hormone [lhrh]
Official title: Luteinising hormone-releasing hormone [LHRH]; Related peptides
C07K7/23 (Luteinising hormone-releasing hormone [lhrh]) appears on 358 US grants and 126 published applications in this corpus.
Search patents in C07K- Granted patents
- 358
- Published applications
- 126
- Assignees
- 153
- Inventors
- 537
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 17 | 0 |
| 1978 | 23 | 0 |
| 1979 | 1 | 0 |
| 1980 | 5 | 0 |
| 1981 | 9 | 0 |
| 1982 | 4 | 0 |
| 1983 | 11 | 0 |
| 1984 | 9 | 0 |
| 1985 | 7 | 0 |
| 1986 | 9 | 0 |
| 1987 | 15 | 0 |
| 1988 | 7 | 0 |
| 1989 | 6 | 0 |
| 1990 | 3 | 0 |
| 1991 | 7 | 0 |
| 1992 | 6 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 9 | 0 |
| 1996 | 18 | 0 |
| 1997 | 17 | 0 |
| 1998 | 22 | 0 |
| 1999 | 12 | 0 |
| 2000 | 13 | 0 |
| 2001 | 18 | 0 |
| 2002 | 4 | 9 |
| 2003 | 8 | 7 |
| 2004 | 9 | 8 |
| 2005 | 6 | 13 |
| 2006 | 5 | 7 |
| 2007 | 1 | 2 |
| 2008 | 2 | 5 |
| 2009 | 3 | 9 |
| 2010 | 4 | 6 |
| 2011 | 5 | 7 |
| 2012 | 3 | 5 |
| 2013 | 6 | 6 |
| 2014 | 5 | 3 |
| 2015 | 7 | 4 |
| 2016 | 3 | 4 |
| 2017 | 2 | 2 |
| 2018 | 3 | 2 |
| 2019 | 0 | 5 |
| 2020 | 2 | 2 |
| 2021 | 4 | 2 |
| 2022 | 1 | 6 |
| 2023 | 1 | 5 |
| 2024 | 3 | 4 |
| 2025 | 1 | 1 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immunotherapeutic for prostate cancer treatment9 Jun 2026US 12,648,985 B2Hexamer Therapeutics, Inc.
- Filamentous nanostructures and their use for treatment of pulmonary disease2 Jun 2026US 12,642,860 B2The Johns Hopkins University
- Compound or salt thereof and preparation method and application of same23 Dec 2025US 12,503,486 B2Zhejiang Peptites Biotech Co., Ltd.
- LHRH-platinum conjugates for treating reproductive cancers26 Nov 2024US 12,152,089 B2Eastern Kentucky University
- Process for the manufacture of degarelix and its intermediates24 Sep 2024US 12,098,218 B2Fresenius Kabi Ipsum S.R.L.
- Method for castration of animals21 May 2026US 2026/0137764 A1Shenzhen Herz Life Science Technology Co., Ltd
- Use of gnrh antagonists in mammals to synchronize follicular wave emergence5 Feb 2026US 2026/0034192 A1University of Saskatchewan
- Method for manufacturing ganirelix3 Apr 2025US 2025/0109170 A1Anygen Co., Ltd.
- Compositions and methods for treating a medical condition12 Sep 2024US 2024/0301090 A1Technion Research & Development Foundation Limited
- Lytic domain fusion constructs, checkpoint inhibitors, and methods of making and using same11 Jul 2024US 2024/0228542 A1A28 Therapeutics Inc.
Most cited
By later US patents
- LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues143US 4,608,251 APitman-Moore, Inc. · 1986
- Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides138US 5,672,659 AKinerton Limited · 1997
- Sustained-release preparation138US 5,972,891 ATakeda Chemical Industries, Ltd. · 1999
- PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH.sub.2 and intermediates122US 3,941,763 AAmerican Home Products Corporation · 1976
- Non-aqueous polar aprotic peptide formulations105US 5,932,547 AAlza Corporation · 1999